Celldex: Pioneering a cure to cancer?

With a promising set of drugs in late-stage clinical trials to treat cancer, Celldex Therapeutics could become the next successful biotech in the US.

Summary: Immuno-oncology is a promising approach to treating a variety of cancers, where drugs are used to awaken the body’s immune system to fight the deadly disease. One of the pioneers in this field, US-based biotech Celldex Therapeutics, is developing a number of these drugs. Its most advanced drug is currently in phase 3 trials and is showing impressive longer-term survival rates.


{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device

Register as a new member

(using a different email)

Related Articles